DK1745287T3 - Diagnostisering og monitorering af inflammatoriske sygdomme ved at måle komplementkomponenter på hvide blodlegemer - Google Patents

Diagnostisering og monitorering af inflammatoriske sygdomme ved at måle komplementkomponenter på hvide blodlegemer

Info

Publication number
DK1745287T3
DK1745287T3 DK05747945.3T DK05747945T DK1745287T3 DK 1745287 T3 DK1745287 T3 DK 1745287T3 DK 05747945 T DK05747945 T DK 05747945T DK 1745287 T3 DK1745287 T3 DK 1745287T3
Authority
DK
Denmark
Prior art keywords
monitoring
blood cells
inflammatory diseases
white blood
diagnosis
Prior art date
Application number
DK05747945.3T
Other languages
English (en)
Inventor
Joseph M Ahearn
Susan M Manzi
Chau-Ching Liu
Original Assignee
Univ Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh filed Critical Univ Pittsburgh
Application granted granted Critical
Publication of DK1745287T3 publication Critical patent/DK1745287T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/973—Simultaneous determination of more than one analyte
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK05747945.3T 2004-05-11 2005-05-11 Diagnostisering og monitorering af inflammatoriske sygdomme ved at måle komplementkomponenter på hvide blodlegemer DK1745287T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57040604P 2004-05-11 2004-05-11
PCT/US2005/016436 WO2005111612A1 (en) 2004-05-11 2005-05-11 Diagnosing and monitoring inflammatory diseases by measuring complement components on white blood cells

Publications (1)

Publication Number Publication Date
DK1745287T3 true DK1745287T3 (da) 2011-01-24

Family

ID=35394276

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05747945.3T DK1745287T3 (da) 2004-05-11 2005-05-11 Diagnostisering og monitorering af inflammatoriske sygdomme ved at måle komplementkomponenter på hvide blodlegemer

Country Status (10)

Country Link
US (3) US7585640B2 (da)
EP (2) EP2214014A1 (da)
JP (1) JP2007537449A (da)
AT (1) ATE482393T1 (da)
AU (1) AU2005242719B2 (da)
CA (1) CA2564492C (da)
DE (1) DE602005023725D1 (da)
DK (1) DK1745287T3 (da)
ES (1) ES2353311T3 (da)
WO (1) WO2005111612A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004232007B2 (en) * 2003-04-16 2009-10-22 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Identification and monitoring of systematic lupus erythematosus
DK1745287T3 (da) * 2004-05-11 2011-01-24 Univ Pittsburgh Diagnostisering og monitorering af inflammatoriske sygdomme ved at måle komplementkomponenter på hvide blodlegemer
JP5117336B2 (ja) * 2008-09-18 2013-01-16 国立大学法人 千葉大学 多発性硬化症またはｎｍｏの検査マーカーの測定方法
AU2009305575A1 (en) * 2008-10-16 2010-04-22 Cypress Bioscience, Inc. Method for diagnosis and monitoring of disease activity and response to treatment in systemic lupus erythematosus (SLE) and other autoimmune diseases
WO2010087594A2 (ko) * 2009-01-28 2010-08-05 한국생명공학연구원 시디９３ 또는 이의 가용성 단편의 용도
WO2012109592A1 (en) 2011-02-11 2012-08-16 Exagen Diagnostics, Inc. Methods for diagnosing systemic lupus erythematosus
US10413620B2 (en) 2012-08-17 2019-09-17 The Regents Of The University Of Colorado, A Body Corporate Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
JP2015535212A (ja) 2012-08-17 2015-12-10 ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・コロラド、ア・ボデイー・コーポレイト 補体活性化を検出するための組成物および方法
US9863946B2 (en) 2013-02-08 2018-01-09 Allegheny-Singer Research Institute Cell-bound complement activation products as diagnostic biomarkers for pre-lupus
RU2680270C2 (ru) * 2013-02-08 2019-02-19 Аллегени-Сингер Рисерч Инститьют Клеточно-связанные продукты активации комплемента в качестве диагностических биомаркеров волчанки в доклинической стадии
CN105229470B (zh) 2013-03-15 2018-11-27 艾克斯肯诊断股份有限公司 用于治疗和诊断系统性红斑狼疮的方法
WO2016023006A1 (en) * 2014-08-08 2016-02-11 Allegheny-Singer Research Institute Anti-lymphocyte autoantibodies as diagnostic biomarkers
EP3191509B1 (en) * 2014-09-09 2019-02-20 Euro-diagnostica AB Antibodies specific for complement component c4d and uses thereof
WO2016048388A1 (en) 2014-09-26 2016-03-31 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof
US10067128B2 (en) * 2015-07-31 2018-09-04 Allegheny-Singer Research Institute Cell-bound complement activation product assays as companion diagnostics for antibody-based drugs
WO2018063914A1 (en) 2016-09-29 2018-04-05 Animantis, Llc Methods and apparatus for assessing immune system activity and therapeutic efficacy
JP7126668B2 (ja) * 2017-08-09 2022-08-29 国立大学法人金沢大学 膠原病判定方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8426467D0 (en) 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
ES2096590T3 (es) 1989-06-29 1997-03-16 Medarex Inc Reactivos biespecificos para la terapia del sida.
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
JPH07509783A (ja) 1992-10-30 1995-10-26 ティー　セル　ダイアグノスティックス，インコーポレーテッド 試料中の全分子の測定及びそれに基づく方法
JP3104197B2 (ja) * 1993-06-11 2000-10-30 ポーラ化成工業株式会社 補体レセプター発現量の測定法
AU2002323691C1 (en) 2001-09-10 2009-03-05 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma
ES2342291T3 (es) * 2003-06-13 2010-07-05 University Of Pittsburgh Control de enfermedades inmunologicas, hematologicas e inflamatorias.
DE602005023009D1 (de) * 2004-04-09 2010-09-30 Univ Pittsburgh Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
DK1745287T3 (da) * 2004-05-11 2011-01-24 Univ Pittsburgh Diagnostisering og monitorering af inflammatoriske sygdomme ved at måle komplementkomponenter på hvide blodlegemer

Also Published As

Publication number Publication date
EP2214014A1 (en) 2010-08-04
JP2007537449A (ja) 2007-12-20
ES2353311T3 (es) 2011-03-01
US20070026387A1 (en) 2007-02-01
WO2005111612A1 (en) 2005-11-24
AU2005242719A1 (en) 2005-11-24
CA2564492C (en) 2012-05-22
AU2005242719B2 (en) 2011-02-24
US20090298198A1 (en) 2009-12-03
US7585640B2 (en) 2009-09-08
US20110275060A1 (en) 2011-11-10
CA2564492A1 (en) 2005-11-24
ATE482393T1 (de) 2010-10-15
EP1745287A1 (en) 2007-01-24
DE602005023725D1 (de) 2010-11-04
EP1745287B1 (en) 2010-09-22
EP1745287A4 (en) 2008-04-16

Similar Documents

Publication Publication Date Title
DK1745287T3 (da) Diagnostisering og monitorering af inflammatoriske sygdomme ved at måle komplementkomponenter på hvide blodlegemer
DK1635692T3 (da) Monitorering af immunologiske, hematologiske og inflammatoriske sygdomme
WO2007062090A8 (en) Methods and compositions related to b cell assays
DK2021796T3 (da) Diagnose af hjerte-kar-sygdom
DE602004032228D1 (de) Optischer sensor mit gewebeüberwucherungskompensation
ATE381334T1 (de) 2,5-substituiertetetrahydroisochinoline zur verwendung als 5-ht6 modulatoren
DK2848938T3 (da) Evaluering af effektiviteten af en behandling hos et individ baseret på st2- niveauer
DK1938839T3 (da) Oftalmiske sammensætninger af parasympatiske stimulanter og anti-inflammatoriske midler til anvendelse i behandlingen af presbyopi
DK1708992T3 (da) Sulfonamidderivater til behandling af sygdomme
DK1266558T3 (da) Mejetærsker med en skråtransportörkraftsensor til måling af afgrödegennemströmningen
DK1604203T3 (da) Fremgangsmåde til direkte bestemmelse af individuelle methotrexatmeta-bolitter
FR2906621B1 (fr) Procede de determination d'une lentille ophtalmique
DK2327792T3 (da) Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme
CY1114523T1 (el) Μεθοδοι για τη θεραπεια των συναισθηματικων διαταραχων
DK1952103T3 (da) Fremgangsmåde til at veje med flere vejeceller
EP1850852A4 (en) USE OF SILDENAFIL, VARDENAFIL AND OTHER 5-PHOSPHODIESTERASE INHIBITORS TO INCREASE THE PERMEABILITY OF THE ABNORMAL BLOOD-BRAIN DISEASE
DK1756571T3 (da) Fremgangsmåde i realtid til detektering af akut inflammatoriske tilstande
BRPI0622419A2 (pt) composições pesticidas e/ou herbicidas e métodos de utilização das mesmas.
IS7811A (is) Aðferðir og prófefni til að meðhöndla sjúkdóma ogkvilla sem tengjast auknu magni af bólguvaldandi frumuboðum
DK1817079T3 (da) Behandling af inflammationer
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
AU2003284234A1 (en) Methods of assessing the risk of reproductive failure by measuring telomere length
FR2885726B1 (fr) Circuit amplificateur de detection pour la detection parallele de quatre niveaux de courant
DK1907579T3 (da) Fremgangsmåde til diagnose af glioma ved at skelne mellem typerne progressive og denovo
FR2871605B3 (fr) Methode pedagogique detectant l'intention de l'apprenant